Literature DB >> 27378753

Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study.

Sangil Lee1, Erik P Hess2, Christine Lohse2, Waqas Gilani2, Alanna M Chamberlain3, Ronna L Campbell2.   

Abstract

BACKGROUND: Anaphylaxis is a potentially life-threatening systemic allergic reaction.
OBJECTIVE: We aimed to determine the incidence rate and causes of anaphylaxis during a 10-year period in Olmsted County, Minnesota.
METHODS: Using the resources of the Rochester Epidemiology Project, a comprehensive records linkage system, we performed a population-based incidence study in Olmsted County, Minnesota, from 2001 through 2010. All cases with a diagnosis of anaphylactic shock and 20% of cases with related diagnoses were manually reviewed. The relationships of age group, sex, and year of anaphylaxis with incidence rates were assessed by fitting Poisson regression models.
RESULTS: Six hundred thirty-one cases of anaphylaxis were identified. The median age was 31 years (interquartile range, 19-44 years). The overall age- and sex-adjusted incidence rate was 42 (95% CI, 38.7-45.3) per 100,000 person-years. There was a significant increase in the overall incidence of anaphylaxis during the study period, with an average increase of 4.3% per year (P < .001). In addition, there was a 9.8% increase per year in the incidence rate of food-related anaphylaxis. Food-related anaphylaxis was most common in children aged 0 to 9 years, venom-related anaphylaxis was most common in those 20 to 39 years of age, and medication-related anaphylaxis was most common in those 30 to 39 years of age.
CONCLUSION: The overall incidence rate of anaphylaxis was 42 per 100,000 person-years from 2001-2010 in Olmsted County, Minnesota. The incidence of anaphylaxis increased over time, and several inciting triggers were uniquely associated with different age groups.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; epidemiology; food allergy; incidence rate; medication allergy; venom allergy

Mesh:

Substances:

Year:  2016        PMID: 27378753      PMCID: PMC5182191          DOI: 10.1016/j.jaci.2016.04.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  37 in total

Review 1.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

2.  Symposium on the definition and management of anaphylaxis: summary report.

Authors:  Hugh A Sampson; Anne Muñoz-Furlong; S Allan Bock; Cara Schmitt; Robert Bass; Badrul A Chowdhury; Wyatt W Decker; Terence J Furlong; Stephen J Galli; David B Golden; Rebecca S Gruchalla; Allen D Harlor; David L Hepner; Marilyn Howarth; Allen P Kaplan; Jerrold H Levy; Lawrence M Lewis; Phillip L Lieberman; Dean D Metcalfe; Ramon Murphy; Susan M Pollart; Richard S Pumphrey; Lanny J Rosenwasser; F Estelle Simons; Joseph P Wood; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes.

Authors:  Faith Huang; Kanwaljit Chawla; Kirsi M Järvinen; Anna Nowak-Węgrzyn
Journal:  J Allergy Clin Immunol       Date:  2011-10-22       Impact factor: 10.793

5.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

6.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

7.  The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

Authors:  Wyatt W Decker; Ronna L Campbell; Veena Manivannan; Anuradha Luke; Jennifer L St Sauver; Amy Weaver; M Fernanda Bellolio; Eric J Bergstralh; Latha G Stead; James T C Li
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

8.  Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Authors:  Kari Bohlke; Robert L Davis; Frank DeStefano; S Michael Marcy; M Miles Braun; Robert S Thompson
Journal:  J Allergy Clin Immunol       Date:  2004-03       Impact factor: 10.793

9.  Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations.

Authors:  Elina Jerschow; Robert Y Lin; Moira M Scaperotti; Aileen P McGinn
Journal:  J Allergy Clin Immunol       Date:  2014-09-30       Impact factor: 10.793

10.  2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Authors:  F Estelle R Simons; Motohiro Ebisawa; Mario Sanchez-Borges; Bernard Y Thong; Margitta Worm; Luciana Kase Tanno; Richard F Lockey; Yehia M El-Gamal; Simon Ga Brown; Hae-Sim Park; Aziz Sheikh
Journal:  World Allergy Organ J       Date:  2015-10-28       Impact factor: 4.084

View more
  29 in total

Review 1.  Sex differences in carcinoid syndrome: A gap to be closed.

Authors:  Rosaria M Ruggeri; Barbara Altieri; Erika Grossrubatcher; Roberto Minotta; Maria Grazia Tarsitano; Virginia Zamponi; Andrea MIsidori; Antongiulio Faggiano; Anna Maria Colao
Journal:  Rev Endocr Metab Disord       Date:  2022-03-16       Impact factor: 6.514

Review 2.  Overview of Allergy and Anaphylaxis.

Authors:  Timothy E Dribin; Megan S Motosue; Ronna L Campbell
Journal:  Emerg Med Clin North Am       Date:  2021-10-29       Impact factor: 2.264

3.  Adrenaline in the Acute Treatment of Anaphylaxis.

Authors:  Johannes Ring; Ludger Klimek; Margitta Worm
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

4.  Trends in US Emergency Department Visits for Anaphylaxis Among Infants and Toddlers: 2006-2015.

Authors:  Lacey B Robinson; Anna Chen Arroyo; Mohammad K Faridi; Susan Rudders; Carlos A Camargo
Journal:  J Allergy Clin Immunol Pract       Date:  2021-01-21

5.  Trends in Emergency Department Visits and Hospitalizations for Acute Allergic Reactions and Anaphylaxis Among US Older Adults: 2006-2014.

Authors:  Anna Chen Arroyo; Lacey B Robinson; Rebecca E Cash; Mohammad Kamal Faridi; Kohei Hasegawa; Carlos A Camargo
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03-30

6.  Characteristics of anaphylaxis patients who visited emergency departments in Korea: Results from a national emergency department information system.

Authors:  Mi-Hee Lee; Eui-Jeong Roh; Yu-Mi Jung; Youngmin Ahn; Eun Hee Chung
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

7.  Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline.

Authors:  Lukas K Gaffney; John Porter; Megan Gerling; Lynda C Schneider; Anne M Stack; Dhara Shah; Kenneth A Michelson
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 9.703

8.  Anaphylaxis in an emergency care setting: a one year prospective study in children and adults.

Authors:  Athamaica Ruiz Oropeza; Annmarie Lassen; Susanne Halken; Carsten Bindslev-Jensen; Charlotte G Mortz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-11-22       Impact factor: 2.953

9.  Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006 to 2015.

Authors:  Lacey B Robinson; Anna Chen Arroyo; Mohammad Kamal Faridi; Susan A Rudders; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2020-09-08       Impact factor: 6.347

10.  Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.

Authors:  Ian A Myles; Joshua S Vinciguerra; Robert T Premus
Journal:  Vaccine       Date:  2021-06-25       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.